Home › Companies › Kura Oncology, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Kura Oncology, Inc.’s Form 8-K, filed June 4, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of June 4, 2026: 7 items on Kura Oncology, Inc.’s Form 8-K, filed June 4, 2026: 3 approved · 4 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore Kura Oncology, Inc. in the interactive database Compare manager voting policies
These tallies are Kura Oncology, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 4, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Diane Parks | 44,060,724 | -- | -- | 14,620,308 | 11,097,548 | 75% | Not verified | — |
| Elect Director: Mary T. Szela | 38,859,502 | -- | -- | 19,821,530 | 11,097,548 | 66% | Not verified | — |
| Elect Director: Michael J. Vasconcelles, M.D. | 58,169,894 | -- | -- | 511,138 | 11,097,548 | 99.1% | Not verified | — |
| 2. Ratification of the Appointment of Independent Registered Public Accounting Firm | 69,385,497 | 140,763 | 252,320 | -- | -- | 99.7% | Approved | — |
| 3. Advisory Vote on Executive Compensation | 48,783,834 | 1,141,854 | 8,755,344 | -- | 11,097,548 | 98% | Not verified | — |
| 5. Approval of our Amended 2014 Plan | 48,402,820 | 10,099,296 | 178,916 | -- | 11,097,548 | 83% | Approved | — |
| 6. Approval of our Amended ESPP | 58,306,174 | 213,434 | 161,424 | -- | 11,097,548 | 99.6% | Approved | — |
Source: Kura Oncology, Inc., Form 8-K, filed with the SEC on June 4, 2026 — read the filing on EDGAR.
Each item below shows how the 202 asset managers that disclosed a Kura Oncology, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Kura Oncology, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
75% Majority: yes · of votes cast
Description as filed by funds: Election of three Class III directors for three-year terms: Diane Parks
Kura Oncology, Inc.’s own tally for this item (“Elect Director: Diane Parks”): 44,060,724 for, 14,620,308 withheld, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 75% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 57 asset managers below reported 10,505,118 for, 5,473,587 withheld, 33 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,962,253 | 0 | 33 | 10,829 | For |
| State Street | 2,070 | 0 | 0 | 2,761,993 | Withhold |
| BlackRock | 2,312,210 | 0 | 0 | 0 | For |
| Fidelity | 2,128,206 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 690,994 | Withhold |
| Dimensional | 0 | 0 | 0 | 474,849 | Withhold |
| American Century | 0 | 0 | 0 | 412,978 | Withhold |
| Nationwide | 22,025 | 0 | 0 | 226,788 | Mixed |
| Columbia Threadneedle | 202,450 | 0 | 0 | 0 | For |
| Equitable | 117,655 | 0 | 0 | 56,700 | Mixed |
| TIAA | 148,083 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 137,018 | 0 | 0 | 0 | For |
| GuideStone | 0 | 0 | 0 | 135,479 | Withhold |
| Invesco | 132,714 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 83,422 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 0 | 82,610 | Withhold |
| Goldman Sachs | 75,398 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 75,304 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 71,906 | Withhold |
| Northern Trust | 0 | 0 | 0 | 60,062 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 57,164 | Withhold |
| Harbor ETF Trust | 55,530 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 40,938 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 38,265 | Withhold |
| Global X | 0 | 0 | 0 | 37,586 | Withhold |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
Combines 2 wordings of this item as funds reported it.
66% Majority: yes · of votes cast
Description as filed by funds: Election of three Class III directors for three-year terms: Mary T. Szela
Kura Oncology, Inc.’s own tally for this item (“Elect Director: Mary T. Szela”): 38,859,502 for, 19,821,530 withheld, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 66% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 57 asset managers below reported 8,220,993 for, 7,757,698 withheld, 46 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,962,240 | 0 | 46 | 10,829 | For |
| State Street | 2,756,416 | 0 | 0 | 7,647 | For |
| BlackRock | 0 | 0 | 0 | 2,312,210 | Withhold |
| Fidelity | 0 | 0 | 0 | 2,128,206 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 690,994 | Withhold |
| Dimensional | 0 | 0 | 0 | 474,849 | Withhold |
| American Century | 0 | 0 | 0 | 412,978 | Withhold |
| Nationwide | 0 | 0 | 0 | 248,813 | Withhold |
| Columbia Threadneedle | 0 | 0 | 0 | 202,450 | Withhold |
| Equitable | 0 | 0 | 0 | 174,355 | Withhold |
| TIAA | 148,083 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 137,018 | Withhold |
| GuideStone | 0 | 0 | 0 | 135,479 | Withhold |
| Invesco | 132,714 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 83,422 | Withhold |
| ETFis Series Trust I | 0 | 0 | 0 | 82,610 | Withhold |
| Goldman Sachs | 75,398 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 75,304 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 71,906 | Withhold |
| Northern Trust | 0 | 0 | 0 | 60,062 | Withhold |
| Lincoln Financial | 55,399 | 0 | 0 | 1,765 | For |
| Harbor ETF Trust | 55,530 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 40,938 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 38,265 | Withhold |
| Global X | 0 | 0 | 0 | 37,586 | Withhold |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Description as filed by funds: Election of three Class III directors for three-year terms: Michael J. Vasconcelles, M.D.
Kura Oncology, Inc.’s own tally for this item (“Elect Director: Michael J. Vasconcelles, M.D.”): 58,169,894 for, 511,138 withheld, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 57 asset managers below reported 15,907,191 for, 71,545 withheld, 1 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,973,114 | 0 | 1 | 0 | For |
| State Street | 2,764,063 | 0 | 0 | 0 | For |
| BlackRock | 2,312,210 | 0 | 0 | 0 | For |
| Fidelity | 2,128,206 | 0 | 0 | 0 | For |
| Charles Schwab | 690,994 | 0 | 0 | 0 | For |
| Dimensional | 474,849 | 0 | 0 | 0 | For |
| American Century | 412,978 | 0 | 0 | 0 | For |
| Nationwide | 248,813 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 202,450 | 0 | 0 | 0 | For |
| Equitable | 117,655 | 0 | 0 | 56,700 | Mixed |
| TIAA | 148,083 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 137,018 | 0 | 0 | 0 | For |
| GuideStone | 135,479 | 0 | 0 | 0 | For |
| Invesco | 132,714 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 83,422 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 82,610 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,398 | 0 | 0 | 0 | For |
| ProShares | 75,304 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 71,906 | 0 | 0 | 0 | For |
| Northern Trust | 60,062 | 0 | 0 | 0 | For |
| Lincoln Financial | 57,164 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 55,530 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 40,938 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 38,265 | 0 | 0 | 0 | For |
| Global X | 37,586 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
99.8% of fund votes cast · no official result
The 57 asset managers below reported 15,948,292 for, 30,445 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,973,115 | 0 | 0 | 0 | For |
| State Street | 2,764,063 | 0 | 0 | 0 | For |
| BlackRock | 2,312,210 | 0 | 0 | 0 | For |
| Fidelity | 2,128,206 | 0 | 0 | 0 | For |
| Charles Schwab | 690,994 | 0 | 0 | 0 | For |
| Dimensional | 474,849 | 0 | 0 | 0 | For |
| American Century | 412,978 | 0 | 0 | 0 | For |
| Nationwide | 248,813 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 202,450 | 0 | 0 | 0 | For |
| Equitable | 174,355 | 0 | 0 | 0 | For |
| TIAA | 148,083 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 137,018 | 0 | 0 | 0 | For |
| GuideStone | 135,479 | 0 | 0 | 0 | For |
| Invesco | 132,714 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 83,422 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 82,610 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,398 | 0 | 0 | 0 | For |
| ProShares | 75,304 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 71,906 | 0 | 0 | 0 | For |
| Northern Trust | 60,062 | 0 | 0 | 0 | For |
| Lincoln Financial | 57,164 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 55,530 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 40,938 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 38,265 | 0 | 0 | 0 | For |
| Global X | 37,586 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
83% Approved · of votes cast
Description as filed by funds: APPROVAL OF AN AMENDMENT TO OUR AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN.
Kura Oncology, Inc.’s own tally for this item (“5. Approval of our Amended 2014 Plan”): 48,402,820 for, 10,099,296 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(5) approved our Amended 2014 Plan”
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 57 asset managers below reported 13,196,998 for, 2,761,951 against, 19,788 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,965,776 | 7,339 | 0 | 0 | For |
| State Street | 2,757,189 | 6,874 | 0 | 0 | For |
| BlackRock | 2,312,210 | 0 | 0 | 0 | For |
| Fidelity | 1,819,898 | 308,308 | 0 | 0 | Mixed |
| Charles Schwab | 690,994 | 0 | 0 | 0 | For |
| Dimensional | 0 | 474,849 | 0 | 0 | Against |
| American Century | 0 | 412,978 | 0 | 0 | Against |
| Nationwide | 26,260 | 222,553 | 0 | 0 | Mixed |
| Columbia Threadneedle | 0 | 202,450 | 0 | 0 | Against |
| Equitable | 117,655 | 56,700 | 0 | 0 | Mixed |
| TIAA | 0 | 148,083 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 137,018 | 0 | 0 | 0 | For |
| GuideStone | 0 | 135,479 | 0 | 0 | Against |
| Invesco | 0 | 132,714 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 83,422 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 82,610 | 0 | 0 | Against |
| Goldman Sachs | 0 | 75,398 | 0 | 0 | Against |
| ProShares | 0 | 75,304 | 0 | 0 | Against |
| ALPS ETF Trust | 0 | 71,906 | 0 | 0 | Against |
| Northern Trust | 0 | 60,062 | 0 | 0 | Against |
| Lincoln Financial | 55,399 | 1,765 | 0 | 0 | For |
| Harbor ETF Trust | 55,530 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 40,938 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 38,265 | 0 | 0 | Against |
| Global X | 37,586 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
Combines 9 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Approval, on an advisory basis, of the compensation of our named executive officers ("Say-on-Pay"), as disclosed in the proxy statement.
Kura Oncology, Inc.’s own tally for this item (“3. Advisory Vote on Executive Compensation”): 48,783,834 for, 1,141,854 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,973,091 | 1 | 22 | 0 | For |
| State Street | 2,762,959 | 1,104 | 0 | 0 | For |
| BlackRock | 2,312,210 | 0 | 0 | 0 | For |
| Fidelity | 2,128,206 | 0 | 0 | 0 | For |
| Charles Schwab | 690,994 | 0 | 0 | 0 | For |
| Dimensional | 474,849 | 0 | 0 | 0 | For |
| American Century | 0 | 412,978 | 0 | 0 | Against |
| Nationwide | 248,813 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 202,450 | 0 | 0 | 0 | For |
| Equitable | 174,355 | 0 | 0 | 0 | For |
| TIAA | 148,083 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 137,018 | 0 | 0 | 0 | For |
| GuideStone | 135,479 | 0 | 0 | 0 | For |
| Invesco | 132,714 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 83,422 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 82,610 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,398 | 0 | 0 | 0 | For |
| ProShares | 75,304 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 71,906 | 0 | 0 | 0 | For |
| Northern Trust | 60,062 | 0 | 0 | 0 | For |
| Lincoln Financial | 57,164 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 55,530 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 40,938 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 38,265 | 0 | 0 | 0 | For |
| Global X | 37,586 | 0 | 0 | 0 | For |
Fund voting reports, all 57 managers: 15,549,786 for, 414,083 against, 14,867 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BVF INC/IL | 0 | 0 | 8,445,769 | 0 | Abstain |
| MONTANOVA CAPITAL, LLC | 6,267,394 | 0 | 0 | 0 | For |
| State Street | 4,270,534 | 14,848 | 0 | 0 | For |
| BlackRock | 3,989,716 | 50,658 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,034,276 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 1,885,890 | 0 | 0 | 0 | For |
| NAN FUNG TRINITY (HK) Ltd | 1,064,880 | 0 | 0 | 0 | For |
| AQR | 956,309 | 0 | 0 | 0 | For |
| 1492 Capital Management LLC | 927,625 | 0 | 0 | 0 | For |
| Logos Global Management LP | 751,331 | 0 | 0 | 0 | For |
| Charles Schwab | 691,219 | 0 | 0 | 0 | For |
| Vanguard | 676,549 | 0 | 0 | 0 | For |
| Northern Trust | 600,985 | 13,736 | 0 | 0 | For |
| Renaissance | 549,885 | 0 | 0 | 0 | For |
| Fisher Asset Management, LLC | 538,715 | 0 | 0 | 0 | For |
| Prosight Management, LP | 467,379 | 0 | 0 | 0 | For |
| Invesco | 452,589 | 0 | 0 | 0 | For |
| American Century | 0 | 442,925 | 0 | 0 | Against |
| ARMISTICE CAPITAL, LLC | 433,193 | 0 | 0 | 0 | For |
| GREAT LAKES ADVISORS, LLC | 339,207 | 0 | 0 | 0 | For |
| SECTOR GAMMA AS | 324,503 | 0 | 0 | 0 | For |
| Fidelity | 319,628 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 282,045 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 247,356 | 0 | 0 | 0 | For |
| DAFNA Capital Management LLC | 235,868 | 0 | 0 | 0 | For |
Institutional-manager reports, all 165 managers: 31,085,608 for, 868,754 against, 8,466,774 abstained, 8,445 not voted, 14,258 1 year, 174 unknown. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: INDICATION, ON AN ADVISORY BASIS, OF THE PREFERRED FREQUENCY OF HOLDING FUTURE SAY-ON-PAY VOTES ON EXECUTIVE COMPENSATION.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 22 | 0 | Abstain |
| State Street | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| Nationwide | 0 | 0 | 0 | 0 | -- |
| Columbia Threadneedle | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| GuideStone | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 0 | -- |
| ETFis Series Trust I | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| ALPS ETF Trust | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| Harbor ETF Trust | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 57 managers: 20,921 for, 14,867 abstained, 15,429,188 1 year, 513,641 3 year, 120 unknown. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BVF INC/IL | 0 | 0 | 8,445,769 | 0 | Abstain |
| MONTANOVA CAPITAL, LLC | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Deep Track Capital, LP | 0 | 0 | 0 | 0 | -- |
| NAN FUNG TRINITY (HK) Ltd | 0 | 0 | 0 | 0 | -- |
| AQR | 0 | 0 | 0 | 0 | -- |
| Logos Global Management LP | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| Fisher Asset Management, LLC | 0 | 0 | 0 | 0 | -- |
| 1492 Capital Management LLC | 0 | 0 | 0 | 0 | -- |
| Prosight Management, LP | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| ARMISTICE CAPITAL, LLC | 0 | 0 | 0 | 0 | -- |
| GREAT LAKES ADVISORS, LLC | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 0 | 0 | 0 | -- |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | 0 | 0 | 0 | -- |
| DAFNA Capital Management LLC | 0 | 0 | 0 | 0 | -- |
| ACADIAN ASSET MANAGEMENT LLC | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 160 managers: 14,258 for, 8,445,769 abstained, 8,445 not voted, 31,031,190 1 year, 156,391 3 year. Showing the 25 largest; see all in the interactive database.
99.7% Approved · of votes cast
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2026.
Kura Oncology, Inc.’s own tally for this item (“2. Ratification of the Appointment of Independent Registered Public Accounting Firm”): 69,385,497 for, 140,763 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(2) ratified the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 57 asset managers below reported 15,963,782 for, 110 against, 14,845 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,973,115 | 0 | 0 | 0 | For |
| State Street | 2,763,953 | 110 | 0 | 0 | For |
| BlackRock | 2,312,210 | 0 | 0 | 0 | For |
| Fidelity | 2,128,206 | 0 | 0 | 0 | For |
| Charles Schwab | 690,994 | 0 | 0 | 0 | For |
| Dimensional | 474,849 | 0 | 0 | 0 | For |
| American Century | 412,978 | 0 | 0 | 0 | For |
| Nationwide | 248,813 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 202,450 | 0 | 0 | 0 | For |
| Equitable | 174,355 | 0 | 0 | 0 | For |
| TIAA | 148,083 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 137,018 | 0 | 0 | 0 | For |
| GuideStone | 135,479 | 0 | 0 | 0 | For |
| Invesco | 132,714 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 83,422 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 82,610 | 0 | 0 | 0 | For |
| Goldman Sachs | 75,398 | 0 | 0 | 0 | For |
| ProShares | 75,304 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 71,906 | 0 | 0 | 0 | For |
| Northern Trust | 60,062 | 0 | 0 | 0 | For |
| Lincoln Financial | 57,164 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 55,530 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 40,938 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 38,265 | 0 | 0 | 0 | For |
| Global X | 37,586 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 88,774,365 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 5.60% |
| 2 | State Street | 3.11% |
| 3 | BlackRock | 2.60% |
| 4 | Fidelity | 2.40% |
| 5 | Charles Schwab | 0.78% |
| 6 | Dimensional | 0.53% |
| 7 | American Century | 0.47% |
| 8 | Nationwide | 0.28% |
| 9 | Columbia Threadneedle | 0.23% |
| 10 | Equitable | 0.20% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BVF INC/IL | 9.51% |
| 2 | MONTANOVA CAPITAL, LLC | 7.06% |
| 3 | State Street | 4.83% |
| 4 | BlackRock | 4.55% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.29% |
| 6 | Deep Track Capital, LP | 2.12% |
| 7 | NAN FUNG TRINITY (HK) Ltd | 1.20% |
| 8 | AQR | 1.08% |
| 9 | 1492 Capital Management LLC | 1.04% |
| 10 | Logos Global Management LP | 0.85% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 10.86% | 13F |
| BVF Partners L.P. | 9.84% | DEF14A |
| Montanova Capital, LLC | 9.66% | 13G |
| Suvretta Capital Management, LLC | 8.52% | DEF14A |
| Vanguard Group | 6.20% | 13F |
| Armistice Capital | 5.56% | DEF14A |
| STATE STREET CORPORATION | 5.55% | 13G |
| Troy E. Wilson, Ph.D., J.D. | 4.13% | DEF14A |
| Geode Capital | 2.29% | 13F |
| Renaissance Technologies | 1.78% | 13F |
Percentages above are of 88,774,365 shares outstanding, as reported by Kura Oncology, Inc. on its Form 10-Q dated May 8, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Kura Oncology, Inc.’s 10-Q dated May 8, 2026. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At Kura Oncology, Inc.'s shareholder meeting held June 4, 2026, in the 2025-2026 proxy season, 202 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,831 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation of our named executive officers… — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Kura Oncology, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 4, 2026.
Kura Oncology, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.